Stereotactic hypofractionated radiotherapy in stage I (T1-2 N0 M0) non-small-cell lung cancer (NSCLC)-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Stereotactic hypofractionated radiotherapy in stage I (T1-2 N0 M0) non-small-cell lung cancer (NSCLC)

Published:2006-01 Issue:7 Volume:45 Page:796-801
ISSN:0284-186X
Container-title:Acta Oncologica
language:en
Short-container-title:Acta Oncologica

Author:

Zimmermann Frank B.,Geinitz Hans,Schill Sabine,Thamm Reinhard,Nieder Carsten,Schratzenstaller Ulrich,Molls Michael

Publisher

Informa UK Limited

Subject

Radiology, Nuclear Medicine and imaging,Oncology,Hematology,General Medicine

Link

http://www.tandfonline.com/doi/pdf/10.1080/02841860600913210

Reference15 articles.

1. Compliance with post-operative adjuvant chemotherapy in non-small cell lung cancer

2. Chemotherapy and Radiotherapy in the Treatment of Resectable Non–Small-Cell Lung Cancer

3. The international system for staging lung cancer

4. Extent of surgery and survival in early lung carcinoma

5. Survival after resection for lung cancer is the outcome that matters

Cited by 136 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Feasibility of a Single-Fraction Stereotactic Dose of 30 Gy to Solitary Lung Lesions on Halcyon;Cureus;2024-05-02

2. A novel and clinically useful weight-optimized dynamic conformal arc in stereotactic radiation therapy of non-small cell lung cancer: Dosimetric comparison of treatment plans with volumetric‐modulated arc therapy;Radiation Physics and Chemistry;2023-02

3. Adaptive hypofractionted and stereotactic body radiotherapy for lung tumors with real-time MRI guidance;Frontiers in Oncology;2023-01-27

4. Lung: Peripheral;Stereotactic Body Radiation Therapy;2023

5. Comparison of stereotactic body radiotherapy and radiofrequency ablation for early-stage non-small cell lung cancer: a systematic review and meta-analysis;Annals of Translational Medicine;2022-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3